• 5-fluorouracil-ebewe

  Form: solution for injection and infusion

  Active substance	Dosage
  fluorouracil	50 mg/ml

  ATC: L01BC02

• Alexan

  Form: solution for injection

  Active substance	Dosage
  Cytarabine	20 mg/1 ml

  ATC: L01BC01

• Alexan

  Form: solution for infusion

  Active substance	Dosage
  Cytarabine	50,000 mg/ml

  ATC: L01BC01

• Carboplatin-ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  carboplatin	10 mg/ml

  ATC: L01XA02

• Cisplatin — ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  Cisplatin	1 mg

  ATC: L01XA01

• Docetaxel-ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  Docetaxel	10 mg/ml

  ATC: L01CD02

• Doxorubicin ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  doxorubicin hydrochloride	10 mg

  ATC: L01DB01

• Epirubicin ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  epirubicin hydrochloride	2 mg/ml

  ATC: L01DB03

• Etoposide ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  Etoposide	20 mg

  ATC: L01CB01

• Gemsol

  Form: solution for infusion, concentrate

  Active substance	Dosage
  gemcitabine hydrochloride	No input provided

  ATC: L01BC05

• Methotrexate-ebewe

  Form: solution for injection

  Active substance	Dosage
  methotrexate	10 mg

  ATC: L01BA01

• Methotrexate-ebewe

  Form: solution for infusion, concentrate

  Active substance	Dosage
  methotrexate	100 mg/ml

  ATC: L01BA01

• Mitoxantrone sandoz

  Form: solution for infusion, concentrate

  Active substance	Dosage
  mitoxantrone	20 mg/10 ml

  ATC: L01DB07

• Pemetrexed sandoz

  Form: solution for infusion, concentrate

  Active substance	Dosage
  pemetrexed disodium 2.5-hydrate	25 mg/ml

  ATC: L01BA04